National Institute on Drug Abuse; Notice of Meeting

[Federal Register Volume 63, Number 11 (Friday, January 16, 1998)]
[Notices]
[Page 2683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-1121]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the National Advisory Council on Drug Abuse, National Institute on 
Drug Abuse (NIDA) on February 3-4, 1998, at the Bethesda Marriott 
Hotel, 5151 Pooks Hill Road, Bethesda, MD 20814.
    On February 3, from 9 a.m. to 4 p.m., in accordance with provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. and sec. 
10(d) of Pub. L. 92-463, this portion of the meeting will be closed to 
the public for the review, discussion, and evaluation of grant 
applications. These applications and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications, disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    On February 4, from 9 a.m. to 5 p.m., this portion of the meeting 
will be open to the public for announcements and reports of 
administrative, legislative, and program developments in the drug abuse 
field. Attendance by the public will be limited to space available.
    A summary of the meeting and a roster of committee members may be 
obtained from Ms. Camilla L. Holland, NIDA Committee Management 
Officer, National Institutes of Health, Parklawn Building, Room 10-42, 
5600 Fishers Lane, Rockville, MD 20857, (301/443-2755).
    Substantive program information may be obtained from Dr. Teresa 
Levitin, Room 10-42, Parklawn Building, 5600 Fishers Lane, Rockville MD 
20857, (301/443-2755).
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact Dr. Levitin in advance of the meeting.

(Catalog of Federal Domestic Assistance Program Numbers: 93.277, 
Drug Abuse Research Scientist Development and Research Scientist 
Awards; 93.278, Drug Abuse National Research Service Awards for 
Research Training; 93.279, Drug Abuse Research Programs)

    Dated: January 8, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-1121 Filed 1-15-98; 8:45 am]
BILLING CODE 4140-01-M